Evidence map›Paper›PMID 36535209›Full record

ArticleComputers in biology and medicine2023

TEMPO: A transformer-based mutation prediction framework for SARS-CoV-2 evolution.

Binbin Zhou, Hang Zhou, Xue Zhang, Xiaobin Xu, Yi Chai, Zengwei Zheng, Alex Chichung Kot, Zhan Zhou

Open access · greenAbstract read
In one paragraph

Article in Computers in biology and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Predicting pathogen evolution and immune evasion in the age of artificial intelligence.Computational and structural biotechnology journal · 2025
    Review
  12. Article
  13. A predictive language model for SARS-CoV-2 evolution.Signal transduction and targeted therapy · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Binbin ZhouDepartment of Computer Science and Computing, Zhejiang University City College, No. 48 Huzhou Street, Hangzhou, 310015, China; Industry Brain Institute, Zhejiang University City College, Hangzhou, 310015, China. Electronic address: bbzhou@zucc.edu.cn.
Hang ZhouDepartment of Computer Science and Computing, Zhejiang University City College, No. 48 Huzhou Street, Hangzhou, 310015, China; College of Computer Science and Technology, Zhejiang University, Hangzhou, 310027, China. Electronic address: hangz@zju.edu.cn.
Xue ZhangInnovation Institute for Artificial Intelligence in Medicine and Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. Electronic address: 22119130@zju.edu.cn.
Xiaobin XuInnovation Institute for Artificial Intelligence in Medicine and Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. Electronic address: 3190104201@zju.edu.cn.
Yi ChaiZJU-UoE Institute, Zhejiang University, Haining, 314400, China. Electronic address: ychai@u.nus.edu.
Zengwei ZhengDepartment of Computer Science and Computing, Zhejiang University City College, No. 48 Huzhou Street, Hangzhou, 310015, China; Industry Brain Institute, Zhejiang University City College, Hangzhou, 310015, China. Electronic address: zhengzw@zucc.edu.cn.
Alex Chichung KotSchool of Electrical and Electronic Engineering, Nanyang Technological University, 639798, Singapore. Electronic address: eackot@ntu.edu.sg.
Zhan ZhouInnovation Institute for Artificial Intelligence in Medicine and Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China; The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China; Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Hangzhou, 310058, China. Electronic address: zhanzhou@zju.edu.cn.
Zhejiang Lab · CNZhejiang University · CNNanyang Technological University · SGZhejiang University of Science and Technology · CNZhejiang University-University of Edinburgh Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread of SARS-CoV-2 presents a significant threat to human society, as well as public health and economic development. Extensive efforts have been undertaken to battle against the pandemic, whereas effective approaches such as vaccination would be weakened by the continuous mutations, leading to considerable attention being attracted to the mutation prediction. However, most previous studies lack attention to phylogenetics. In this paper, we propose a novel and effective model TEMPO for predicting the mutation of SARS-CoV-2 evolution. Specifically, we design a phylogenetic tree-based sampling method to generate sequence evolution data. Then, a transformer-based model is presented for the site mutation prediction after learning the high-level representation of these sequence data. We conduct experiments to verify the effectiveness of TEMPO, leveraging a large-scale SARS-CoV- 2 dataset. Experimental results show that TEMPO is effective for mutation prediction of SARS- CoV-2 evolution and outperforms several state-of-the-art baseline methods. We further perform mutation prediction experiments of other infectious viruses, to explore the feasibility and robustness of TEMPO, and experimental results verify its superiority. The codes and datasets are freely available at https://github.com/ZJUDataIntelligence/TEMPO.

Indexed as

COVID-19SARS-CoV-2HumansMutationPandemicsPhylogenyMutation predictionNatural language processingPhylogenetic treeSARS-CoV-2Transformer-based methodViral evolution

Identifiers

PMID36535209
PMCPMC9747230
OpenAlexW4311278799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.